Navigation Links
InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
Date:1/22/2009

The Company's groundbreaking products are featured in Genetic Engineering News for delivering the promise of safety without sacrificing productivity and performance.

Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria's product line was featured in the Jan. 15, 2009 edition of Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, entitled Culture Media Underlies Productivity Gains, referenced the productivity and safety improvements achieved through cell culture media optimization. New media components, such as InVitria's animal free recombinant media, have contributed to these improvements.

Test results have confirmed that InVitria's recombinant albumin (Cellastim™) outperforms plasma-derived human serum albumin and results in productivity improvements in CHO and hybridoma cell lines.

InVitria's recombinant lactoferrin (Lacromin™) is a strong cell growth factor and is capable of performing better in cell culture media than insulin and insulin-like growth factors. Research has shown Lacromin™ to be a major advance in promoting cell growth and productivity across a variety of cell lines.

Also mentioned in the article is InVitria's Lysobac™, a cell lysis reagent used in microbial fermentation to improve recombinant protein yield and deliver consistent quality, as well as the safety of an animal free reagent. Lysobac™ is many times more active than chicken lysozyme.

InVitria's performance enhancing recombinants offer producers affordable, well-defined and regulatory compliant cell culture media and bacterial lysis components. They can also contribute to operational efficiency and reduced capital costs.

"InVitria is committed to improving our customers' cell culture and bacterial fermentation performance by producing safe, consistent and affordable components," said Scott Deeter, President of InVitria. "We have been greatly encouraged by the results InVitria customers have achieved using our products. We hope to build upon these successes and share with the bioprocessing, diagnostic and stem cell and regenerative medicine communities the power of InVitria's products."

About InVitria
InVitria manufactures and sells animal free components for cell culture media and bacterial lysis. InVitria's affordable products can enhance cell growth, reduce doubling times and optimize performance for the bioprocessing, stem cell and regenerative medicine, life science and diagnostics markets.

Learn more about InVitria's products at InVitria

Contact InVitria's product customer service specialists by e-mail or phone.

Phone: 1-800-916-8311

# # #

Read the full story at http://www.prweb.com/releases/genengnews/invitria/prweb1898894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
3. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
4. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
5. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
6. InVitria Expands Sales Team
7. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
8. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
9. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
10. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
11. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... N.J. , Feb. 3, 2016 ... totaling more than $1 million for researchers in ... working on health-related research that demonstrates exciting potential. ... round of funding for the New Jersey Health Foundation ... faculty members at these educational institutions— Princeton University, ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases ... from Vigilant Solutions. Brian Wenberg explains, ... victim was walking out of a convenience store and witnessed an elderly male ... vehicle, striking his vehicle and leaving the scene.  In ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... ( www.wocketwallet.com ) announces the launch of a new video featuring singer, ... Las Vegas , where Joey appeared at the Wocket booth to ... , where Joey appeared at the Wocket booth to meet and greet ... the Consumer Electronics Show (CES2016) in Las Vegas , ... --> --> The video is ...
Breaking Biology News(10 mins):